December 2, 2025

Acadia Healthcare Company, Inc. (ACHC) Stock Analysis: Navigating a 50% Potential Upside Amidst Market Volatility

Acadia Healthcare Company, Inc. (NASDAQ: ACHC) stands out in the healthcare sector, particularly within the medical care facilities industry, as it continues to cater to the..

Vericel Corporation (VCEL) Stock Analysis: Exploring a 43.52% Potential Upside in Biotech

Vericel Corporation (NASDAQ: VCEL), a notable player in the biotechnology sector, is capturing the interest of investors with its impressive potential for growth. With a current..

Mirum Pharmaceuticals, Inc. (MIRM) Stock Analysis: Strong Buy Ratings Signal Potential 25.69% Upside

Mirum Pharmaceuticals, Inc. (MIRM), a biopharmaceutical company headquartered in Foster City, California, is capturing the attention of investors with its promising portfolio and robust analyst endorsements...

Addus HomeCare Corporation (ADUS) Stock Analysis: A Potential 17% Upside in the Healthcare Sector

Addus HomeCare Corporation (NASDAQ: ADUS) is drawing significant attention from investors within the healthcare sector, primarily due to its robust growth potential and promising analyst ratings...

Kymera Therapeutics (KYMR): Analyst Consensus Signals 16% Upside in Innovative Biotech Space

Kymera Therapeutics, Inc. (NASDAQ: KYMR), a trailblazer in the biotechnology sector, is gaining attention from investors with its innovative approach to drug development. The company, headquartered..

Immunovant, Inc. (IMVT) Stock Analysis: Unpacking a 70% Upside Potential

Immunovant, Inc. (NASDAQ: IMVT), a clinical-stage biotechnology company, is increasingly becoming a focal point for investors seeking opportunities in the healthcare sector. With a substantial market..

Merus N.V. (MRUS) Stock Analysis: Navigating the Biotech Landscape with 1.10% Potential Upside

Merus N.V. (NASDAQ: MRUS), a prominent player in the biotechnology sector, is gaining attention in the investment community. With a current market capitalization of $7.28 billion,..

GeneDx Holdings Corp. (WGS) Stock Analysis: A Steady Performer in the Genomics Space with 51.9% Revenue Growth

GeneDx Holdings Corp. (NASDAQ: WGS), a prominent player in the healthcare sector, specifically within the diagnostics and research industry, continues to make notable strides in the..

Alignment Healthcare, Inc. (ALHC) Stock Analysis: Strong Revenue Growth and Analyst Confidence Signal Potential Upside

Alignment Healthcare, Inc. (NASDAQ: ALHC) stands out in the healthcare sector as a provider specializing in consumer-centric platforms for seniors, particularly through its Medicare Advantage plans...

QuidelOrtho Corporation (QDEL) Stock Analysis: A 42% Potential Upside in the Healthcare Sector

QuidelOrtho Corporation (NASDAQ: QDEL) is making waves in the healthcare sector with a significant potential upside of 42.25%, according to analyst consensus. Specializing in diagnostic testing..

LifeStance Health Group, Inc. (LFST) Stock Analysis: Exploring a 32.61% Potential Upside in the Mental Health Sector

Investors with a keen interest in the healthcare sector might find LifeStance Health Group, Inc. (NASDAQ: LFST) a compelling prospect. Specializing in outpatient mental health services,..

Arrowhead Pharmaceuticals (ARWR) Stock Analysis: Assessing Its 1.78% Potential Upside and Promising Drug Pipeline

Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) continues to capture investor attention with its innovative approach to tackling intractable diseases through RNA interference (RNAi) technology. With a robust..

Amneal Pharmaceuticals (AMRX) Stock Analysis: Navigating Growth with a 9.67% Potential Upside

Amneal Pharmaceuticals, Inc. (NASDAQ: AMRX), a key player in the healthcare sector specializing in both generic and specialty drug manufacturing, presents an intriguing opportunity for investors..

Organon & Co. (OGN) Stock Analysis: Exploring a 27% Potential Upside Amidst a Volatile Market

Organon & Co. (OGN), a prominent player in the healthcare sector specializing in drug manufacturing, has captured investor attention with its diverse portfolio and strategic global..

Metsera, Inc. (MTSR) Investor Outlook: Navigating a 19.15% Potential Downside Amidst Biotech Innovations

Metsera, Inc. (MTSR), a clinical-stage biotechnology company based in New York, has garnered significant attention in the healthcare sector, particularly with its innovative approach to tackling..

Zai Lab Limited (ZLAB) Investor Outlook: 148.93% Upside Potential in the Biotech Sector

Zai Lab Limited (NASDAQ: ZLAB), a prominent player in the biopharmaceutical landscape, is gaining attention from investors, particularly with its staggering potential upside of 148.93%. Based..

Warby Parker Inc. (WRBY) Stock Analysis: Eyeing a 17.97% Potential Upside Amidst Strong Revenue Growth

Warby Parker Inc. (NYSE: WRBY), a prominent player in the healthcare sector, especially within the medical instruments and supplies industry, continues to make waves in the..

Haemonetics Corporation (HAE) Stock Analysis: A Healthcare Play with a Solid Buy Consensus

For investors keen on the medical devices sector, Haemonetics Corporation (NYSE: HAE) presents a compelling opportunity. With a market capitalization of $3.9 billion, this Boston-based company..

Sotera Health Company (SHC) Stock Analysis: 9.10% Potential Upside Amid Robust Revenue Growth

Sotera Health Company (SHC), a prominent player in the healthcare sector, specializes in providing essential sterilization, lab testing, and advisory services across the United States and..

CRISPR Therapeutics AG (CRSP) Stock Analysis: Exploring a Potential 55.9% Upside with Revolutionary Gene Editing Technology

As CRISPR Therapeutics AG (NASDAQ: CRSP) navigates the promising yet volatile waters of the biotechnology sector, individual investors are keenly eyeing its potential upside of 55.9%,..

Search

Funds

December 2, 2025

Search

Funds

December 2, 2025

FTSE 100

Funds